‘Hellow’ Volunteer Program Provides Tangible Support to Underprivileged Communities and Strengthens Local Engagement
Alvogen Korea (CEO: Woo-se Lee) extended warmth to underprivileged members of the community through its annual Kimchi Sharing volunteer activity on November 14. This employee-led initiative, launched in 2013, has continued for 13 consecutive years.
The Kimchi Sharing activity is part of Alvogen Korea’s flagship corporate social responsibility (CSR) program, Hellow Kitchen, organized by the company’s internal CSR group More Son in partnership with the Dimode Children’s Center in Seoul. Volunteers—including both club members and employees—prepared approximately 200 portions of kimchi. The kimchi was then delivered to welfare institutions that support economically vulnerable individuals, including social assistance recipients and senior care facilities.
Every year, Alvogen Korea carries out a variety of CSR initiatives, including the Kimchi Sharing program, to provide practical support that meets the daily needs of those in welfare blind spots. By actively involving employees in hands-on volunteer activities, the company fosters a genuine culture of giving while deepening meaningful ties with the local community.
Jung Hye-sun, Director of the Dimode Children’s Center, remarked, “We are grateful to the Alvogen Korea employees who share their warmth with us every year. The carefully prepared kimchi offers meaningful support to the children and local seniors, making it a heartfelt contribution that goes beyond simple assistance.”
CEO Woo-se Lee stated, “The 13-year tradition of Kimchi Sharing reflects Alvogen Korea’s commitment to supporting neighbors in need and our responsibility toward the community. We will continue striving to grow alongside our local communities and contribute to a society where everyone can live healthy lives through sincere and impactful CSR activities.”
As the Korean branch of global healthcare company Lotus, Alvogen Korea provides tangible support to those in welfare blind spots through its social contribution brand Hellow, which represents “bright and healthy smiles.” Programs such as Hellow Kitchen, Hellow Care, and Hellow Kids deliver practical assistance in healthcare, daily living, and nutrition, helping establish a sustainable CSR model that creates real impact in everyday life.
Founded in 1966, Lotus (1795: TT) is an international pharmaceutical company with a global presence, focused on commercializing both novel and generic pharmaceuticals to provide patients with better, safer, and more accessible medicines. The company boasts a best-in-class R&D and manufacturing platform in Asia, certified by leading regulatory authorities around the world, including the US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA. Lotus has established partnerships in nearly every major global market, including the U.S., Europe, Japan, China, and Brazil. The company is currently developing and registering over 100 strategically selected pharmaceutical projects across Asia and the U.S., with more than 250 commercial products. Lotus invests in a diversified portfolio, consisting of high-barrier oncology, complex generics, 505(b)2, NCEs, and biosimilars, through both internal R&D investments and licensing-in partnerships to strengthen its portfolio competitiveness.
Yihsuan Kuo, Investor Relations Assistant Manager
Jeffrey Tsang, Head of Investor Relations and Corporate Communications
+886 2 2700 5908
investor@lotuspharm.com
